editedbook
Publication: IIP Proceedings Year: 2022, Month: November Page No: 1-14, ISSN/ISBN: 978-93-95632-87-4, DOI/Link: https://rsquarel.org/assets/docupload/rsl202378E650C0AF1B37D.pdf
ENDOMETRIOSIS
Area/Stream: Pharmacy & Nursing, Authors: Dr. Ayesha Tayyiba Keywords: Deep Infiltrating Endometriosis, Apoptosis, Dysmenorrhea, Menstruation, Biomarkers, Laproscopy Book Name /series: Futuristic Trends in Pharmacy & Nursing, Volume 2, Book 25, Part 1, Chapter 1Publication: IIP Proceedings Year: 2022, Month: November Page No: 1-14, ISSN/ISBN: 978-93-95632-87-4, DOI/Link: https://rsquarel.org/assets/docupload/rsl202378E650C0AF1B37D.pdf
Abstract:
Endometriosis is a chronic gynaecological disorder that can lead to infertility and pelvic pain in adults and women of reproductive age. It is characterized by the presence of endometrial like-glands and stroma outside the uterine cavity. It is influenced by various risk factors like early menarche, late menopause and lifestyle. Numerous etiologic factors are linked to menstruation, genetics and hormones. With age, the diagnosis and severity of endometriosis rises up. Ultrasound, laproscopy, magnetic resonance imagings are the common diagnostic tools. Endometriosis has been classified into four stages by American Society of Reproductive Medicine based on the severity. Prevalence in women is around 2 to 50%. Endometriotic lesions can appear as red, brown, yellow, white, clear, black, pink or red vesicles and are hormonally active, responding to cyclical variations in oestrogen and progesterone.
Cite this: Dr. Ayesha Tayyiba,"ENDOMETRIOSIS", Futuristic Trends in Pharmacy & Nursing, Volume 2, Book 25, Part 1, Chapter 1, November, 2022, 1-14, 978-93-95632-87-4, https://rsquarel.org/assets/docupload/rsl202378E650C0AF1B37D.pdf
Views: 4163
Download File
News
